Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 5.30 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CorMedix Inc | CRMD | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.09 | 1.73% | 5.30 | 5.47 | 5.03 | 5.14 | 5.21 | 17:30:47 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,089 | 152,224 | $ 5.28 | $ 803,062 | 276,302 | 4.20 - 13.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:30:00 | 4,231 | $ 5.30 | USD |
CorMedix Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 159.35M | 30.07M | $ -26.83M | -1.50 | - | 25.72M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 3.91M | $ - | 0.00% | 8.00 | 18.20% |
CorMedix News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRMD Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.16 | 6.2958 | 4.86 | 5.2913 | 479k | -0.86 | -13.96% |
| 1 Month | 8.25 | 8.64 | 4.86 | 6.3133 | 322k | -2.95 | -35.76% |
| 3 Months | 9 | 9.93 | 4.86 | 7.5010 | 262k | -3.7 | -41.11% |
| 6 Months | 9.11 | 9.99 | 4.86 | 7.7627 | 351k | -3.81 | -41.82% |
| 1 Year | 12 | 13.7 | 4.2 | 8.2579 | 2M | -6.7 | -55.83% |
| 3 Years | 12.9 | 13.7 | 0.8605 | 4.9818 | 1M | -7.6 | -58.91% |
| 5 Years | 7.85 | 52 | 0.8605 | 8.1023 | 1M | -2.55 | -32.48% |
CorMedix Description
| Cormedix Inc is a US-based biopharmaceutical company which focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution or the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as dialysis, critical/intensive care, and oncology. The Neutrolin product is designed to target unmet medical need. |
